| Abstract: | Four experiments were conducted to determine the effect of length of treatment, stage of cycle at start of treatment and administration of oestradiol benzoate or progesterone at the start of treatment with intravaginal progesterone coils on oestrous response and fertility. In Experiment 1, the number of heifers in oestrus was affected neither by injection of 5 mg oestradiol benzoate alone or with 200 mg progesterone nor by length of treatment. More heifers (P < 0.05) were in oestrus on day 2 after treatment following a 12-day treatment compared to a 9-day treatment.In Experiment 2, heifers between days 17 and 20 of the oestrous cycle received an injection of either 5 mg oestradiol benzoate alone or with 200 mg progesterone at the start of a 9-day treatment with progesterone coils. Neither the number of heifers in oestrus nor the pattern of onset were affected after treatment. In Experiment 3, heifers between days 0 and 3 of the oestrus cycle received progesterone coils for 9, 12 or 14 days. In addition, animals received (i) no further treatment, (ii) a gelatin capsule adhered to the coil containing 10 mg oestradiol benzoate (iii) a gelatin capsule adhered to the coil containing 200 mg progesterone. Following a 9- or 12-day treatment period heifers receiving the coil with the oestrogen capsule had a high oestrous response ( compared to , P < 0.05). When oestrogen was not given, there was a significant linear effect of duration of treatment on the number in oestrus (9 days, ; 12 days ; 14 days, ; P < 0.05).In Experiment 4, post-partum cows were used to compare a 9- and 12-day treatment period and half the animals in each group received either 5 mg oestradiol benzoate and 200 mg progesterone at the start of treatment or a 10 mg gelatin capsule adhered to the coil. The length of treatment affected the number of heifers in oestrus since were in oestrus after a 12-day treatment period compared with after a 9-day period (P < 0.001). There were no significant differences in the number of cows in oestrus after injection of oestrogen and progesterone () or after the use of the gelatin capsule (). |
